Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03039881 · ClinicalTrials.gov registry record
Evaluation of Non-Invasive Respiratory Volume Monitor
A clinical trial, sponsored by Tufts Medical Center.
- Completed
- Registry status
- 150
- Enrollment target
NCT03039881: Completed study, sponsored by Tufts Medical Center.
NCT03039881 is a clinical trial that has completed, run by Tufts Medical Center. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03039881 has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This observational study investigates the validity and utility of a new, non-significant risk, FDA approved respiratory monitor, ExSpiron, in the perioperative course of patients undergoing elective surgery under general anesthesia. The study patients will be monitored before, during and after surgery, in post-anaesthesia care unit (PACU) and recovery room for the first post-operative night. The physiologic data will not be used or influence the standard of care for subjects. It is anticipated that this monitor may be able to improve perioperative care in the future.
Primary Outcome
Low minute ventilation (LMV) defined as sustained LMV\<40% minute ventilation predicted (MVPRED) based on IBW following opioid administration correlates with adverse clinical outcomes in PACU and on the floor
Interventions
- DEVICE Non-Invasive Respiratory Volume Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2015-01-09 |
| Est. Completion | 2019-01-08 |
What the finished NCT03039881 record still lists
NCT03039881 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Non-Invasive Respiratory Volume Monitor is the first listed.
NCT03039881 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03039881 about?
NCT03039881 is a clinical study titled "Evaluation of Non-Invasive Respiratory Volume Monitor". This observational study investigates the validity and utility of a new, non-significant risk, FDA approved respiratory monitor, ExSpiron, in the perioperative course of patients undergoing elective surgery under general anesthesia. The study patients will be monitored before, during and after surge...
What is the current status of trial NCT03039881?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2015-01-09. Estimated completion is 2019-01-08.
What interventions are being tested in trial NCT03039881?
The interventions under investigation include: Non-Invasive Respiratory Volume Monitor (DEVICE).
Who is sponsoring clinical trial NCT03039881?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI